Petra Steinacker

9PUBLICATIONS
22CO-AUTHORS
Nanotoxicology, health and safetyNeurology and neuromuscular diseasesInstrumental methods (excl. immunological and bioassay methods)Central nervous systemBiological adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 17, 2026
Serum as an alternative to plasma for determining the ApoE4 phenotype using Pan-ApoE and ApoE4 chemiluminescent enzyme immunoassays.

Eric Kortmann, Petra Steinacker, Arthur Guthknecht

|Oct 08, 2025
CSF Beta-Synuclein, SNAP-25, and Neurogranin in Infectious and Autoimmune Inflammatory Neurologic Diseases.

Samir Abu-Rumeileh, Deborah K Erhart, Lorenzo Barba

|Aug 21, 2025
Evidence for reduced synaptic protein SNAP-25 in cerebrospinal fluid in major depressive disorder and schizophrenia.

Petra Steinacker, Leonie Werner, Alexander Tarabuko

|Aug 22, 2022
CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer's disease.

Steffen Halbgebauer, Petra Steinacker, Sophie Hengge

|Aug 09, 2022
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease.

Lorenzo Barba, Samir Abu Rumeileh, Giovanni Bellomo

|Apr 28, 2022
Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion.

Patrick Oeckl, Sarah Anderl-Straub, Christine A F Von Arnim

Pageof 2

Frequent Collaborators

7 joint publications

Patrick Oeckl

7 joint publications

Markus Otto

3 joint publications

Steffen Halbgebauer

3 joint publications

Samir Abu-Rumeileh